OpenAI partners with NATO on cybersecurity under Daybreak initiative
Published 2 d ago3 sourcesEvidence: Reported
Merck announced a research collaboration with Isomorphic Labs, the AI drug discovery firm built on DeepMind's AlphaFold technology. The deal signals continued pharma investment in AI-driven target discovery, though financial terms and specific therapeutic areas are not disclosed. It underscores the growing integration of AI into early-stage drug R&D pipelines.
AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works
Entities
Published 2 d ago3 sourcesEvidence: Reported
Published 2 d ago1 sourceEvidence: Reported
Published 10 h ago1 sourceEvidence: Reported
Published 12 h ago1 sourceEvidence: Reported
Published 2 d ago12 sourcesEvidence: Reported
Published 1 d ago8 sourcesEvidence: Reported
Published 1 d ago6 sourcesEvidence: Reported
Published 2 d ago9 sourcesEvidence: Reported